Mental Health DailyResearch. Evidence. Perspective.Published research on methylphenidate.
Among people prescribed ADHD medication in 5 health systems, recorded self-harm was most common in the 3 months before their first prescription, not after it.1 Risk fell once treatment began…
Read articleA 2026 multi-cohort fMRI study found that a signal often treated as physiological noise tracked nicotine dependence, cue-induced craving, abstinence, and stimulant effects.1 During cigarette…
Read articleA 2026 double-blind randomized controlled trial by Kappes et al. in Psychopharmacology found something the smart-drug users likely wouldn’t have predicted: a single 30 mg dose of methylpheni…
Read articleIn the pursuit of peak mental performance, scientific studies have explored the effects of stimulants like methylphenidate, modafinil, and caffeine on cognitive functions such as memory and …
Read articleRitalin is a psychostimulant drug used medically for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. It contains the active ingredient methylphenidate, which…
Read articleMethylphenidate is considered the first medication approved for the treatment of the condition known as “hyperactivity” in the 1960s. As attention-deficit/hyperactivity disorder gained more …
Read articleFrom a historical perspective, one of the most popular ADHD medications of all time is Ritalin. It was first approved by the FDA in 1955 for treating a condition referred to as “hyperactivit…
Read article
